News Article
Candesic ranked number one consultant advisor in the medical and pharmaceutical sector by number of transactions
We are pleased to share that as of the end of 2025, Candesic ranked number one consultant advisor in the medical and pharmaceutical sector by number of transactions over the preceding three year period (Mergermarket).
This recognition capped a very positive year for Candesic, having successfully opened our New York office and having won three of the most prestigious industry awards: Real Deals Private Equity Award for ‘CDD Provider of the Year’, HealthInvestor Awards for ‘Consultants of the year – Strategic’ and LaingBuisson Awards for ‘Consultancy of the Year’.
Our recent success reflects years of commitment from a brilliant team of which we could not be more proud, and the trust of our clients.
Thank you to everyone who has been part of the journey so far; we’re looking forward to what comes next.

